Benefit of adjuvant chemotherapy in patients with lobular breast cancer: A systematic review of the literature and metanalysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefit of adjuvant chemotherapy in patients with lobular breast cancer: A systematic review of the literature and metanalysis
Authors
Keywords
Lobular breast cancer, Adjuvant chemotherapy, Lobular cancer, Benefit of treatments, Early breast cancer
Journal
CANCER TREATMENT REVIEWS
Volume 97, Issue -, Pages 102205
Publisher
Elsevier BV
Online
2021-04-09
DOI
10.1016/j.ctrv.2021.102205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2019 WHO classification of tumours of the breast
- (2020) Puay Hoon Tan et al. HISTOPATHOLOGY
- E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
- (2020) Matthias Christgen et al. MODERN PATHOLOGY
- How to treat lobular cancer in the adjuvant setting?
- (2020) Dario Trapani et al. CURRENT OPINION IN ONCOLOGY
- CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?
- (2020) Antonio C. Wolff JOURNAL OF CLINICAL ONCOLOGY
- Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- (2020) Stephen R. D. Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study
- (2020) Richard Buus et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
- (2019) Alexandre de Nonneville et al. BREAST CANCER RESEARCH AND TREATMENT
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
- (2019) J M S Bartlett et al. ANNALS OF ONCOLOGY
- Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
- (2019) Aleix Prat et al. LANCET ONCOLOGY
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer
- (2018) Xiang-Hong Chen et al. Biomarkers in Medicine
- Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade
- (2018) Otto Metzger‐Filho et al. ONCOLOGIST
- Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer
- (2017) Masayuki Inoue et al. Breast Cancer
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Treatment choices for patients with invasive lobular breast cancer: a doctor survey
- (2015) Carmel Jacobs et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
- (2013) Y Delpech et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer
- (2012) W. Truin et al. ANNALS OF ONCOLOGY
- Invasive lobular breast cancer: subtypes and outcome
- (2012) Monica Iorfida et al. BREAST CANCER RESEARCH AND TREATMENT
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Survival of breast cancer patients with meningeal carcinomatosis
- (2010) H. Gauthier et al. ANNALS OF ONCOLOGY
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
- (2009) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
- (2008) Leonard Da Silva et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials
- (2008) Bernhard C. Pestalozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
- Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
- (2007) Emad A. Rakha et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now